Brief: Thermogenesis Announces That It Has Notified The FDA Of Its Intent To Distribute Co's Rapid Covid-19 Point-Of-Care Test Kit
March 31 (Reuters) - Thermogenesis Holdings Inc THMO.O :
* THERMOGENESIS ANNOUNCES THAT IT HAS NOTIFIED THE FDA OF
ITS
INTENT TO DISTRIBUTE THE COMPANY'S RAPID COVID-19 POINT-OF-CARE
TEST KIT
Source text for Eikon: ID:nPn8B8Hjfa
Further company coverage: THMO.O
((Briefs@thomsonreuters.com;))
Recent news on Thermogenesis Holdings
See all newsThermogenesis Holdings Inc expected to post earnings of 1 cent a share - Earnings Preview
Thermogenesis Holdings Inc reports results for the quarter ended in December - Earnings Summary
Thermogenesis Holdings Inc expected to post a loss of 1 cent a share - Earnings Preview
Thermogenesis Holdings Inc expected to post a loss of 1 cent a share - Earnings Preview
Brief: Thermogenesis Holdings Says On Jan 8 Co Received Nasdaq Letter Notifying It No Longer Complies With Minimum Bid Price Requirement For Listing On Nasdaq